Repeat expansion analyses were performed for 414 amyotrophic lateral sclerosis patients and 713 neurologically normal controls; pathogenic and intermediate-length repeat expansions in AR, ATXN2 and HTT were observed in 3.1% of the amyotrophic lateral sclerosis patients (Fig. 1). This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.